This Biotech June Catalyst: What Investors Need to Know Now
A major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
Coping with unexpected personal finance challenges involves rapid assessment, prioritizing essentials, and building a short-term recovery plan you can follow.
15,758 articlesA major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
Two senior researchers depart the Ethereum Foundation, intensifying leadership churn. Market watchers split on whethe...
A mixed quarter and a tougher backdrop pushed KE Holdings shares lower, underscoring how market forces and sector hea...
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
The AFL-CIO argues the Senate version of the CLARITY Act could channel digital assets into retirement accounts with w...
As global tensions rise, borrowing costs and lenders' risk appetites shift. This guide explains why the housing marke...
As mortgage rates and prices wobble, first-time buyers face a tougher path. Experts urge a disciplined plan and reali...
The S&P 500 climbs for an eighth straight week as ten of eleven sectors rise, with healthcare leading and AI-related ...
In a volatile energy market, two durable picks stand out as no-brainer energy stocks right for many portfolios. Learn...
Investors rushing tips etfs have flooded inflation hedges amid stubborn price pressures, yet experts warn the protect...
Intel has powered a 492% surge in a year, but a wave of insider selling has traders weighing how durable the rebound ...
Investors are seeing renewed momentum in xanadu quantum technologies stock as talk of government support and industry...